Subchronic administration of fluoxetine impairs estrous behavior in intact female rats

Neuropsychopharmacology

Volumn 19, Issue 6, 1998, Pages 492-498

  Matuszczyk, Josefa Vega ^a   Larsson, Knut ^a   Eriksson, Elias ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Estrus; Fluoxetine; Lordosis; Rat; Serotonin; Sexual behavior

Indexed keywords

ESTRADIOL; FLUOXETINE; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; COITUS; ESTRUS; FEMALE; GONADECTOMY; LORDOSIS; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; SEXUAL BEHAVIOR;

ANIMALS; ESTRUS; FEMALE; FLUOXETINE; MOTIVATION; POSTURE; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; SEXUAL BEHAVIOR, ANIMAL; TIME FACTORS; VAGINA;

EID: 0031722460     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00040-2     Document Type: Article

References (46)

1. Ahlenius S., Fernandez-Guasti A., Hjorth S., Larsson K. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat. Eur J Pharmacol. 124:1986;361-363.
2. Ahlenius S., Heimann M., Larsson K. Prolongation of the ejaculation latency in the male rat by thioridazine and chlorimipramine. Psychopharmacology. 65:1979;137-140.
3. Ahlenius S., Larsson K., Fernandez-Guasti A. Evidence for the involvement of central 5-HT1A receptors in the mediation of lordosis behavior in the female rat. Psychopharmacology. 98:1989;440-444.
4. Allen D.L., Renner K.J., Luine V.N. Pargyline-induced increase in serotonin levels. Correlation with inhibition of lordosis in rats Pharmacol Biochem Behav. 45:1993;837-841.
5. Balon R. Fluoxetine and sexual dysfunction. JAMA. 273:1995;1489.
6. Beach F.A. Sexual attractivity, proceptivity, and receptivity in female mammals. Horm Behav. 7:1976;105-138.
7. Eriksson E., Hedberg A., Andersch B., Sundblad C. The serotonin re-uptake inhibitor paroxetine is superior to the noradrenaline re-uptake inhibitor maprotiline in the treatment of premenstrual syndrome. A placebo-controlled trial Neuropsychopharmacology. 12:1995;167-175.
8. Eriksson E., Humble M. Serotonin in psychiatric pathophysiology. A review of data from experimental and clinical research. Pohl R., Gershon S. The Biological Basis of Psychiatric Treatment. 1990;66-119 Karger, Basel.
9. Everitt B.J. Monoamines and sexual behavior in nonhuman primates. Ciba Found Symp. 16:1978;329-358.
10. Everitt B.J., Fuxe K., Hökfelt T. Inhibitory role of dopamine and 5-hydroxytryptamine in the sexual behavior of female rats. Eur J Pharmacol. 29:1974;187-191.
11. Feiger A., Kiev A., Shrivastava R.K., Wisselink P.G., Wilcox C.S. Nefazodone versus sertraline in outpatients with major depression. Focus on efficacy, tolerability, and effects on sexual function and satisfaction J Clin Psychiat. 57:1996;53-62.
12. Frankfurt M., Renner K., Azmitia E., Luine V. Intrahypothalamic 5,7-dihydroxytryptamine. Temporal analysis of effects on 5-hydroxytryptamine content in brain nuclei and on facilitated lordosis behavior Brain Res. 340:1985;127-133.
13. Fuller R.W., Wong D.T., Robertson D.W. Fluoxetine, a selective inhibitor of serotonin uptake. Med Res Rev. 11:1991;17-34.
14. Gradwell P.B., Everitt F.J., Herbert J. 5-Hydroxytryptamine in the central nervous system and sexual receptivity of female rhesus monkeys. Brain Res. 88:1975;281-293.
15. Herman J.B., Brotman A.W., Pollack M.H., Falk W.E., Biederman J., Rosenbaum J.F. Fluoxetine-induced sexual dysfunction. J Clin Psychiat. 51:1990;25-27.
16. Hsu J.H., Shen W.W. Male sexual side effects associated with antidepressants. A descriptive clinical study of 32 patients Int J Psychiat Med. 25:1995;191-201.
17. Hunter A.J., Hole D.R., Wilson C.A. Studies into the dual effects of serotonergic pharmacological agents on female sexual behavior in the rat. Preliminary evidence that endogenous 5HT is stimulatory Pharmacol Biochem Behav. 22:1985;5-13.
18. Kara H., Aydin S., Yücel M., Agargün M.Y., Odabas O., Yilmaz Y. The efficacy of fluoxetine in the treatment of premature ejaculation. A double-blind placebo-controlled study J Urol. 156:1996;1631-1632.
19. Long J.A., Evans H.M. The oestrous cycle in the rat and its associated phenomena. Mem Univ California. 6:1922;1-148.
20. Luine V.N., Paden C.M. Effects of monoamine oxidase inhibition on female sexual behavior, serotonin levels and type A and B monoamine oxidase activity. Neuroendocrinology. 34:1982;245-251.
21. Maj J., Moryl E. Effects of fluoxetine given chronically on the responsiveness of 5-HT receptor subpopulations to their agonists. Eur Neuropsychopharmacol. 3:1993;85-94.
22. Marvan M.L., Chavez-Chavez L., Santana S. Clomipramine modifies fluctuations of forced swimming immobility in different phases of the rat estrous cycle. Arch Med Res. 27:1996;83-86.
23. Maswood S., Uphouse L. Disruption of female rat vaginal cyclicity by daily treatment with imipramine. Reprod Toxicol. 6:1992;319-322.
24. Mendelson S.D., Gorzalka B.B. A facilitatory role for serotonin in the sexual behavior of the female rat. Pharmacol Biochem Behav. 22:1985;1025-1033.
25. Meyerson B.J. Estrus behavior in spayed rats after estrogen or progesterone treatment in combination with reserpine or tetrabenazine. Psychopharmacology. 6:1964;210-218. a.
26. Meyerson B.J. The effect of neuropharmacological agents on hormone-activated estrus behavior in ovraiectomised rats. Arch Int Pharmacodynam. 150:1964;4-33. b.
27. Meyerson B.J., Carrer H., Eliasson M. 5-Hydroxytryptamine and sexual behavior in the female rat. Adv Biochem Psychopharmacol. 11:1974;229-242.
28. Meyerson B.J., Eliasson M., Hetta J. Sex-specific orientation in female and male rats. Development and effects of early endocrine manipulations Acta Physiol Scand. 453:1978;29-46.
29. Meyerson B.J., Lewander T. Serotonin synthesis inhibition and estrous behavior in female rats. Life Sci. 9:1970;661-671.
30. Monteiro W.O., Noshirvani H.F., Marks I.M., Lelliott P.T. Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial. Br J Psychiat. 151:1987;107-112.
31. Muse K.N., Cetel N.S., Futterman L.A., Yen S.C. The premenstrual syndrome. Effects of "medical ovariectomy" N Engl J Med. 311:1984;1345-1349.
32. Shen W.W., Hsu J.H. Female sexual side effects associated with selective serotonin reuptake inhibitors. A descriptive clinical study of 33 patients Int J Psychiat Med. 25:1995;239-248.
33. Steiner M., Steinberg S., Stewart D., Carter D., Berger C., Reid R., Grover D., Streiner D. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med. 332:1995;1529-1534.
34. Sundblad C., Modigh K., Andersch B., Eriksson E. Clomipramine effectively reduces premenstrual irritability and dysphoria. A placebo-controlled trial Acta Psychiat Scand. 85:1992;39-47.
35. Sundblad C., Wikander I., Andersch B., Eriksson E. A naturalistic study of paroxetine in premenstrual syndrome. Efficacy and side-effects during 10 cycles of treatment Eur Neuropsychopharm. 7:1997;201-206.
36. Taylor G., Bardgett M., Csernansky J., Early T., Haller J., Scherrer J., Womack S. Male reproductive systems under chronic fluoxetine or trimipramine treatment. Physiol Behav. 59:1996;479-485.
37. Uphouse L., Caldarola-Pastuszka M. Female sexual behavior following intracerebral infusion of the 5-HT1A agonist, 8-OH-DPAT, into the medical preoptic area. Brain Res. 601:1993;203-208.
38. Uphouse L., Caldarola-Pastuszka M., Montanez S. Intracerebral actions of the 5-HT1A agonists, 8-OH-DPAT and buspirone and of the 5-HT1A partial agonist/antagonist, NAN-190, on female sexual behavior. Neuropharmacol. 31:1992;969-981.
39. Uphouse L., Montanez S., Richards-Hill R., Caldarola-Pastuszka M., Droge M. Effects of the 5-HT1A agonist, 8-OH-DPAT, on sexual behaviors of the proestrous rat. Pharmacol Biochem Behav. 39:1991;635-640.
40. Vega Matuszczyk J, Larsson K (1993): Sexual orientation and sexual motivation of the adult male rat. Physiol Behav 53:747-750.
41. Vega Matuszczyk J., Larsson K., Eriksson E. The selective serotonin reuptake inhibitor fluoxetine reduces sexual motivation in male rats. Pharmacol Biochem Behav. 60:1998;527-532.
42. Waldinger M.D., Hengeveld M.W., Zwinderman A.H. Paroxetine treatment of premature ejaculation. A double-blind, randomized, placebo-controlled study Am J Psychiat. 151:1994;1377-1379.
43. Wikander I, Sundblad C, Andersch B, Dagnell I, Zylberstain D, Eriksson E: Citalopram in premenstrual dysphoria: is intermittent treatment more effective than continuous administration? J Clin Psychopharmacol 1998, in press.
44. Yells D., Prendergast M.A., Hendricks S.E., Miller M.E. Monoaminergic influences on temporal patterning of sexual behavior in male rats. Physiol Behav. 58:1995;847-852.
45. Yells D.P., Prendergast M.A., Hendricks S.E., Nakamura M. Fluoxetine-induced inhibition of male rat copulatory behavior. Modification by lesions of the nucleus paragigantocellularis Pharm Biochem Behav. 49:1994;121-127.
46. Zajecka J., Fawcett J., Schaff M., Jeffriess H., Guy C. The role of serotonin in sexual dysfunction. Fluoxetine-associated orgasm dysfunction J Clin Psychiat. 52:1991;66-68.